Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Zhiwei Wu; Yaling Hu; Miao Xu; Zhen Chen; Wanqi Yang; Zhiwei Jiang; Minjie Li; Hui Jin; Guoliang Cui; Panpan Chen; Lei Wang; Guoqing Zhao; Yuzhu Ding; Yuliang Zhao; Weidong Yin

The Lancet Infectious Diseases (2021) - Comments
doi: 10.1016/s1473-3099(20)30987-7 issn: 1473-3099 pubmed: 33548194 issn: 1474-4457

Zhiwei Wu, Yaling Hu, Miao Xu, Zhen Chen, Wanqi Yang, Zhiwei Jiang, Minjie Li, Hui Jin, Guoliang Cui, Panpan Chen, Lei Wang, Guoqing Zhao, Yuzhu Ding, Yuliang Zhao, Weidong Yin